WETORI-P contains Etoricoxib 60 mg + Paracetamol 325 mg, offering complementary anti-inflammatory, analgesic and antipyretic action for selected painful conditions. A useful PCD Pharma Anti-Inflammatory portfolio product.
Painful inflammatory musculoskeletal conditions.
To provide additional analgesic and antipyretic support.
Use only as prescribed and avoid exceeding recommended Paracetamol intake from all sources. Monitor BP and inform the doctor about cardiovascular, kidney or liver disease.
Indigestion, nausea, dizziness, headache, edema and abdominal discomfort may occur.
WETORI-P: Etoricoxib selectively inhibits COX-2 to reduce inflammation and pain, while Paracetamol provides complementary analgesic and antipyretic action.
